Lower BP May Be Harmful For CKD Patients

Lower BP May Be Harmful For CKD PatientsAccording to a health specialist, lower blood pressure level could be harmful for people suffering from chronic kidney disease (CKD).

Recent guidelines by The National Kidney Foundation Disease Outcomes Quality Initiative (NKF KDOQI) require lower target blood pressure levels in CKD sufferers.

But without high-quality scientific proof, there's a chance this recommendation could do more harm than good, according to Julia B. Lewis, MD (Vanderbilt University, Nashville, TN), who performed a critical review of the research evidence.

Julia said, "The new low blood pressure goals are not definitively supported by data, would be costly to the healthcare system and potentially harmful to patients."

Issued during 2009, updated national guidelines for CKD treatment call for a target BP level of less than 130/80 mm Hg (millimeters of mercury) to help preserve kidney function.

The suggestion was based on observational researches indicating "a continuous benefit of reducing blood pressure to lower and lower levels."

But, she indicates several troubles with the study behind the new guidelines.

Most importantly, since patients in the observational studies were not randomly assigned to different blood pressure goals, the apparent benefit of lower blood pressures could result from other "confounding" factors.

She explains that, as kidney problem grow worse, BP level increases and turns harder to control. So the information may simply reflect the fact that patients with less severe kidney disease have lower BP level.

In researches where patients were randomly assigned to treatments, the benefits of lower BP were seen only in a subgroup of patients, or several years after the end of treatment.

Some researches have even suggested that CKD patients with very low blood pressure could be at increased risk of death.

A new trial sponsored by the National Institutes of Health (NIH) will compare the effects of different blood pressure targets in over 10,000 patients with CKD. Until the results are available, Lewis believes that doctors should make individualized decisions about blood pressure control for their patients with kidney disease.

The article appears in a forthcoming issue of the Journal of the American Society Nephrology (JASN). (With Inputs from Agencies)